Clinical Trial Update: Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating pemetrexed disodium with cisplatin, with or without cediranib, in malignant pleural mesothelioma; results were posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelioid Mesothelioma
• Malignant Mesothelioma
• Malignant Pleural Mesothelioma
• Sarcomatoid Mesothelioma

Drugs mentioned

• Alimta (Pemetrexed disodium) (pemetrexed disodium)
• CISPLATIN (cisplatin)
• Cediranib (Cediranib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Epithelioid Mesothelioma, Pleural Malignant Mesothelioma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-02-05